A revolutionary gene therapy experiment at Moorfields Eye Hospital in London has resulted in significant sight improvements for four toddlers born with a severe form of childhood blindness. These children, who were legally blind before the therapy, are now showing remarkable progress in their ability to see after receiving the experimental treatment, which involved injecting healthy copies of a defective gene into the back of their eyes.
The trial, published in the Lancet medical journal, is providing hope for children with rare genetic conditions that cause rapid vision deterioration from birth. In the case of these toddlers, their parents have reported life-changing improvements, with some children now able to engage in activities like drawing and writing for the first time. The success of this gene therapy builds upon previous advancements in treating genetic blindness, with similar treatments being available on the NHS since 2020.
One of the children who benefited from this groundbreaking procedure is Jace, a six-year-old from Connecticut in the United States. Jace’s parents discovered his eye condition when he was just a baby, leading to a diagnosis of a rare genetic mutation that affected his vision. Following the gene therapy treatment in London, Jace’s progress has been described as “pretty amazing” by his father, with noticeable improvements in his ability to see and interact with the world around him.
The experimental therapy, which involves injecting healthy genes into the retina at the back of the eye, offers new hope for young children with severe genetic eye conditions. Professor James Bainbridge, a retinal surgeon at Moorfields Eye Hospital, emphasized the importance of early intervention in improving children’s sight and development. The results of this trial have been regarded as “hugely impressive” by medical professionals, who plan to continue monitoring the children to assess the long-term effects of the gene therapy.
Overall, this innovative gene therapy experiment is paving the way for new treatment options for children with genetic blindness, showcasing the potential for gene therapy to transform lives and improve vision for those who have no other alternatives available to them. The promising results of this trial highlight the power of medical advancements in tackling rare genetic conditions and providing hope for families facing similar challenges
Read the full article from The BBC here: Read More
